vs
Esperion Therapeutics, Inc.（ESPR）与Resolute Holdings Management, Inc.（RHLD）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是Resolute Holdings Management, Inc.的1.4倍（$168.4M vs $117.7M）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
ESPR vs RHLD — 直观对比
营收规模更大
ESPR
是对方的1.4倍
$117.7M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $117.7M |
| 净利润 | — | $-1.7M |
| 毛利率 | — | 55.7% |
| 营业利润率 | 50.6% | 30.2% |
| 净利率 | — | -1.5% |
| 营收同比 | 143.7% | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.32 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRRHLD
| Q4 25 | $168.4M | $117.7M | ||
| Q3 25 | $87.3M | $120.9M | ||
| Q2 25 | $82.4M | $119.6M | ||
| Q1 25 | $65.0M | $103.9M | ||
| Q4 24 | $69.1M | — | ||
| Q3 24 | $51.6M | — | ||
| Q2 24 | $73.8M | — | ||
| Q1 24 | $137.7M | — |
净利润ESPRRHLD
| Q4 25 | — | $-1.7M | ||
| Q3 25 | $-31.3M | $-231.0K | ||
| Q2 25 | $-12.7M | $-611.0K | ||
| Q1 25 | $-40.5M | $-3.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-29.5M | — | ||
| Q2 24 | $-61.9M | — | ||
| Q1 24 | $61.0M | — |
毛利率ESPRRHLD
| Q4 25 | — | 55.7% | ||
| Q3 25 | — | 59.0% | ||
| Q2 25 | — | 57.5% | ||
| Q1 25 | — | 52.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ESPRRHLD
| Q4 25 | 50.6% | 30.2% | ||
| Q3 25 | -11.4% | 34.3% | ||
| Q2 25 | 8.6% | 34.0% | ||
| Q1 25 | -34.0% | 24.7% | ||
| Q4 24 | -6.4% | — | ||
| Q3 24 | -31.0% | — | ||
| Q2 24 | 3.5% | — | ||
| Q1 24 | 52.5% | — |
净利率ESPRRHLD
| Q4 25 | — | -1.5% | ||
| Q3 25 | -35.9% | -0.2% | ||
| Q2 25 | -15.4% | -0.5% | ||
| Q1 25 | -62.2% | -3.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | -57.2% | — | ||
| Q2 24 | -83.9% | — | ||
| Q1 24 | 44.3% | — |
每股收益（稀释后）ESPRRHLD
| Q4 25 | $0.32 | $-0.20 | ||
| Q3 25 | $-0.16 | $-0.03 | ||
| Q2 25 | $-0.06 | $-0.07 | ||
| Q1 25 | $-0.21 | $-0.39 | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $-0.15 | — | ||
| Q2 24 | $-0.33 | — | ||
| Q1 24 | $0.34 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $205.5M |
| 总债务越低越好 | — | $169.8M |
| 股东权益账面价值 | $-302.0M | $6.5M |
| 总资产 | $465.9M | $333.4M |
| 负债/权益比越低杠杆越低 | — | 26.03× |
8季度趋势，按日历期对齐
现金及短期投资ESPRRHLD
| Q4 25 | $167.9M | $205.5M | ||
| Q3 25 | $92.4M | $148.0M | ||
| Q2 25 | $86.1M | $99.9M | ||
| Q1 25 | $114.6M | $71.0M | ||
| Q4 24 | $144.8M | — | ||
| Q3 24 | $144.7M | — | ||
| Q2 24 | $189.3M | — | ||
| Q1 24 | $226.6M | — |
总债务ESPRRHLD
| Q4 25 | — | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ESPRRHLD
| Q4 25 | $-302.0M | $6.5M | ||
| Q3 25 | $-451.4M | $10.8M | ||
| Q2 25 | $-433.5M | $9.6M | ||
| Q1 25 | $-426.2M | $8.9M | ||
| Q4 24 | $-388.7M | — | ||
| Q3 24 | $-370.2M | — | ||
| Q2 24 | $-344.2M | — | ||
| Q1 24 | $-294.3M | — |
总资产ESPRRHLD
| Q4 25 | $465.9M | $333.4M | ||
| Q3 25 | $364.0M | $293.2M | ||
| Q2 25 | $347.1M | $253.3M | ||
| Q1 25 | $324.0M | $214.3M | ||
| Q4 24 | $343.8M | — | ||
| Q3 24 | $314.1M | — | ||
| Q2 24 | $352.3M | — | ||
| Q1 24 | $373.1M | — |
负债/权益比ESPRRHLD
| Q4 25 | — | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | — | $189.2M |
| 自由现金流率自由现金流/营收 | — | 160.8% |
| 资本支出强度资本支出/营收 | 0.0% | 5.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $313.2M |
8季度趋势，按日历期对齐
经营现金流ESPRRHLD
| Q4 25 | $45.2M | $196.1M | ||
| Q3 25 | $-4.3M | $59.6M | ||
| Q2 25 | $-31.4M | $48.9M | ||
| Q1 25 | $-22.6M | $18.4M | ||
| Q4 24 | $-35.0M | — | ||
| Q3 24 | $-35.3M | — | ||
| Q2 24 | $-7.2M | — | ||
| Q1 24 | $53.8M | — |
自由现金流ESPRRHLD
| Q4 25 | — | $189.2M | ||
| Q3 25 | — | $58.6M | ||
| Q2 25 | — | $47.5M | ||
| Q1 25 | — | $17.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-35.5M | — | ||
| Q2 24 | $-7.3M | — | ||
| Q1 24 | $53.8M | — |
自由现金流率ESPRRHLD
| Q4 25 | — | 160.8% | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 39.7% | ||
| Q1 25 | — | 17.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | -68.7% | — | ||
| Q2 24 | -9.9% | — | ||
| Q1 24 | 39.0% | — |
资本支出强度ESPRRHLD
| Q4 25 | 0.0% | 5.8% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.0% | 1.2% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
现金转化率ESPRRHLD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
RHLD
暂无分部数据
